Apply to Cambridge Angels

Apply to Cambridge Angels

Abselion Appoints Dale Gordon as Chair

23 Mar

Written By Alexandra Collingbourne

Alexandra Collingbourne

Bristol spin-out Albotherm awarded its first UK patent

Monument Therapeutics Announces First Patient Dosed in Clinical Trial of MT1988 in Patients at Clinical High Risk for Psychosis